Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.

Dystrophin is a long rod-shaped protein that connects the subsarcolemmal cytoskeleton to a complex of proteins in the surface membrane (dystrophin protein complex, DPC), with further connections via laminin to other extracellular matrix proteins. Initially considered a structural complex that protected the sarcolemma from mechanical damage, the DPC is now known to serve as a scaffold for numerous signaling proteins. Absence or reduced expression of dystrophin or many of the DPC components cause the muscular dystrophies, a group of inherited diseases in which repeated bouts of muscle damage lead to atrophy and fibrosis, and eventually muscle degeneration. The normal function of dystrophin is poorly defined. In its absence a complex series of changes occur with multiple muscle proteins showing reduced or increased expression or being modified in various ways. In this review, we will consider the various proteins whose expression and function is changed in muscular dystrophies, focusing on Ca(2+)-permeable channels, nitric oxide synthase, NADPH oxidase, and caveolins. Excessive Ca(2+) entry, increased membrane permeability, disordered caveolar function, and increased levels of reactive oxygen species are early changes in the disease, and the hypotheses for these phenomena will be critically considered. The aim of the review is to define the early damage pathways in muscular dystrophy which might be appropriate targets for therapy designed to minimize the muscle degeneration and slow the progression of the disease.

[1]  K. Lim,et al.  Eteplirsen in the treatment of Duchenne muscular dystrophy , 2017, Drug design, development and therapy.

[2]  E. Füchtbauer,et al.  Lack of the serum- and glucocorticoid-inducible kinase SGK1 improves muscle force characteristics and attenuates fibrosis in dystrophic mdx mouse muscle , 2015, Pflügers Archiv - European Journal of Physiology.

[3]  D. Swandulla,et al.  Simultaneous Pathoproteomic Evaluation of the Dystrophin-Glycoprotein Complex and Secondary Changes in the mdx-4cv Mouse Model of Duchenne Muscular Dystrophy , 2015, Biology.

[4]  Paul L Huang,et al.  Loss of nNOS inhibits compensatory muscle hypertrophy and exacerbates inflammation and eccentric contraction-induced damage in mdx mice. , 2015, Human molecular genetics.

[5]  B. Loos,et al.  AHNAK: the giant jack of all trades. , 2014, Cellular Signalling.

[6]  H. Brinkmeier,et al.  Chaperoning heat shock proteins: Proteomic analysis and relevance for normal and dystrophin‐deficient muscle , 2014, Proteomics. Clinical applications.

[7]  A. López de Munain,et al.  Dysregulation of calcium homeostasis in muscular dystrophies , 2014, Expert Reviews in Molecular Medicine.

[8]  G. Reiser,et al.  Putative roles of Ca2+‐independent phospholipase A2 in respiratory chain‐associated ROS production in brain mitochondria: influence of docosahexaenoic acid and bromoenol lactone , 2014, Journal of neurochemistry.

[9]  P. Muñoz-Cánoves,et al.  Novel and optimized strategies for inducing fibrosis in vivo: focus on Duchenne Muscular Dystrophy , 2014, Skeletal Muscle.

[10]  C. Spurney,et al.  Cooperative international neuromuscular research group duchenne natural history study demonstrates insufficient diagnosis and treatment of cardiomyopathy in duchenne muscular dystrophy , 2014, Muscle & nerve.

[11]  D. Goodlett,et al.  Phosphorylation within the cysteine-rich region of dystrophin enhances its association with β-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wasting. , 2014, Human molecular genetics.

[12]  H. Sweeney,et al.  Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function , 2014, Neuromuscular Disorders.

[13]  M. Sardiello,et al.  Src-dependent impairment of autophagy by oxidative stress in a mouse model of Duchenne muscular dystrophy , 2014, Nature Communications.

[14]  E. Barton,et al.  Caspase-12 ablation preserves muscle function in the mdx mouse. , 2014, Human molecular genetics.

[15]  H. Westerblad,et al.  Nitrosative modifications of the Ca2+ release complex and actin underlie arthritis-induced muscle weakness , 2014, Annals of the rheumatic diseases.

[16]  E. Hoffman,et al.  Exon-Skipping Therapy: A Roadblock, Detour, or Bump in the Road? , 2014, Science Translational Medicine.

[17]  M. Gasperini,et al.  Dystrophic muscle improvement in zebrafish via increased heme oxygenase signaling. , 2014, Human molecular genetics.

[18]  T. Palmer,et al.  Cavin-1: caveolae-dependent signalling and cardiovascular disease. , 2014, Biochemical Society transactions.

[19]  M. Adams,et al.  Role of SNTA1 in Rac1 activation, modulation of ROS generation, and migratory potential of human breast cancer cells , 2014, British Journal of Cancer.

[20]  R. Goldschmeding,et al.  Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy. , 2013, Human molecular genetics.

[21]  R. Finkel,et al.  Phase 2a Study of Ataluren-Mediated Dystrophin Production in Patients with Nonsense Mutation Duchenne Muscular Dystrophy , 2013, PloS one.

[22]  L. Ségalat,et al.  Chemical genetics unveils a key role of mitochondrial dynamics, cytochrome c release and IP3R activity in muscular dystrophy. , 2013, Human molecular genetics.

[23]  T. Yoshimori,et al.  The autophagosome: origins unknown, biogenesis complex , 2013, Nature Reviews Molecular Cell Biology.

[24]  F. Muntoni,et al.  194th ENMC international workshop. 3rd ENMC workshop on exon skipping: Towards clinical application of antisense-mediated exon skipping for Duchenne muscular dystrophy 8–10 December 2012, Naarden, The Netherlands , 2013, Neuromuscular Disorders.

[25]  Eric P Hoffman,et al.  Orphan drug development in muscular dystrophy: update on two large clinical trials of dystrophin rescue therapies. , 2013, Discovery medicine.

[26]  E. Ralston,et al.  Microtubules that form the stationary lattice of muscle fibers are dynamic and nucleated at Golgi elements , 2013, The Journal of cell biology.

[27]  C. Buechler,et al.  Adiponectin receptor 1 C-terminus interacts with PDZ-domain proteins such as syntrophins. , 2013, Experimental and molecular pathology.

[28]  U. Ruegg Pharmacological prospects in the treatment of Duchenne muscular dystrophy , 2013, Current opinion in neurology.

[29]  T. Partridge The mdx mouse model as a surrogate for Duchenne muscular dystrophy , 2013, The FEBS journal.

[30]  C. McDonald,et al.  Why short stature is beneficial in duchenne muscular dystrophy , 2013, Muscle & nerve.

[31]  E. McNally,et al.  Modifying muscular dystrophy through transforming growth factor‐β , 2013, The FEBS journal.

[32]  Stephan Lange,et al.  Cypher/ZASP Is a Novel A-kinase Anchoring Protein* , 2013, The Journal of Biological Chemistry.

[33]  Haixia Huang,et al.  Caveolae Regulation of Mechanosensitive Channel Function in Myotubes , 2013, PloS one.

[34]  K. Flanigan,et al.  Identification of New Dystroglycan Complexes in Skeletal Muscle , 2013, PloS one.

[35]  Michael Berk,et al.  The chemistry and biological activities of N-acetylcysteine. , 2013, Biochimica et biophysica acta.

[36]  Jay J. Han,et al.  The cooperative international neuromuscular research group Duchenne natural history study: Glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measur , 2013, Muscle & nerve.

[37]  Jian Yang,et al.  Structure and function of the β subunit of voltage-gated Ca²⁺ channels. , 2013, Biochimica et biophysica acta.

[38]  J. Penninger,et al.  Linking cytoarchitecture to metabolism: sarcolemma-associated plectin affects glucose uptake by destabilizing microtubule networks in mdx myofibers , 2013, Skeletal Muscle.

[39]  Elaine Minatel,et al.  N-acetylcysteine treatment reduces TNF-α levels and myonecrosis in diaphragm muscle of mdx mice. , 2013, Clinical nutrition.

[40]  K. Davies,et al.  Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches , 2013, Nature Reviews Genetics.

[41]  M. Hammadi,et al.  Modulation of ER stress and apoptosis by endoplasmic reticulum calcium leak via translocon during unfolded protein response: involvement of GRP78 , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  W. Bloch,et al.  Skeletal Muscle Function during Exercise—Fine-Tuning of Diverse Subsystems by Nitric Oxide , 2013, International journal of molecular sciences.

[43]  E. Clementi,et al.  Autophagy as a new therapeutic target in Duchenne muscular dystrophy , 2013, Cell Death and Disease.

[44]  L. Kunkel,et al.  Zebrafish based small molecule screens for novel DMD drugs. , 2013, Drug discovery today. Technologies.

[45]  J. Mendell,et al.  AAV-mediated overexpression of human α7 integrin leads to histological and functional improvement in dystrophic mice. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[46]  M. Jackson,et al.  Studies of mitochondrial and nonmitochondrial sources implicate nicotinamide adenine dinucleotide phosphate oxidase(s) in the increased skeletal muscle superoxide generation that occurs during contractile activity. , 2013, Antioxidants & redox signaling.

[47]  Jimmy D Bell,et al.  Ca2+‐dependent proteolysis of junctophilin‐1 and junctophilin‐2 in skeletal and cardiac muscle , 2013, The Journal of physiology.

[48]  J. Lawler,et al.  Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy , 2013, Journal of Muscle Research and Cell Motility.

[49]  Y. Hathout,et al.  Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion , 2013, Cellular and Molecular Life Sciences.

[50]  Robert G. Parton,et al.  Caveolae as plasma membrane sensors, protectors and organizers , 2013, Nature Reviews Molecular Cell Biology.

[51]  Louise R. Rodino-Klapac,et al.  Update on the Treatment of Duchenne Muscular Dystrophy , 2013, Current Neurology and Neuroscience Reports.

[52]  L. Wells The O-Mannosylation Pathway: Glycosyltransferases and Proteins Implicated in Congenital Muscular Dystrophy* , 2013, The Journal of Biological Chemistry.

[53]  E. Hoffman,et al.  Identification of Disease Specific Pathways Using in Vivo SILAC Proteomics in Dystrophin Deficient mdx Mouse* , 2013, Molecular & Cellular Proteomics.

[54]  Jamie L. Marshall,et al.  Sarcospan: a small protein with large potential for Duchenne muscular dystrophy , 2013, Skeletal Muscle.

[55]  R. Elashoff,et al.  Tadalafil Alleviates Muscle Ischemia in Patients with Becker Muscular Dystrophy , 2012, Science Translational Medicine.

[56]  P. Gervais,et al.  Exploration of Lipid Metabolism in Relation with Plasma Membrane Properties of Duchenne Muscular Dystrophy Cells: Influence of L-Carnitine , 2012, PloS one.

[57]  D. Duan,et al.  α2 and α3 helices of dystrophin R16 and R17 frame a microdomain in the α1 helix of dystrophin R17 for neuronal NOS binding , 2012, Proceedings of the National Academy of Sciences.

[58]  Xiaoli Zhao,et al.  Orai1 Mediates Exacerbated Ca2+ Entry in Dystrophic Skeletal Muscle , 2012, PloS one.

[59]  S. Froehner,et al.  The Light Chains of Microtubule-Associated Proteins MAP1A and MAP1B Interact with α1-Syntrophin in the Central and Peripheral Nervous System , 2012, PloS one.

[60]  S. Winder,et al.  The inside and out of dystroglycan post-translational modification , 2012, Neuromuscular Disorders.

[61]  S. Winder,et al.  Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse. , 2012, Human molecular genetics.

[62]  K. Anderson,et al.  β2-syntrophin and Par-3 promote an apicobasal Rac activity gradient at cell-cell junctions by differentially regulating Tiam1 activity , 2012, Nature Cell Biology.

[63]  J. Mendell,et al.  Gene therapy for muscular dystrophy: Lessons learned and path forward , 2012, Neuroscience Letters.

[64]  P. Lesault,et al.  Macrophages Improve Survival, Proliferation and Migration of Engrafted Myogenic Precursor Cells into MDX Skeletal Muscle , 2012, PloS one.

[65]  T. Grimm,et al.  Survival in Duchenne muscular dystrophy , 2012, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[66]  F. Leturcq,et al.  G.P.75 Variable phenotype of del45–55 Becker patients correlated to nNOSμ mislocalization and RYR1 hypernitrosylation , 2012, Neuromuscular Disorders.

[67]  M. Welte,et al.  Organelle positioning in muscles requires cooperation between two KASH proteins and microtubules , 2012, The Journal of cell biology.

[68]  J. Beavo,et al.  Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy , 2012, The Journal of pathology.

[69]  Shuo Lin,et al.  Fatigue and Muscle Atrophy in a Mouse Model of Myasthenia Gravis Is Paralleled by Loss of Sarcolemmal nNOS , 2012, PloS one.

[70]  Michael A. Freitas,et al.  Proteomic Analysis Reveals New Cardiac-Specific Dystrophin-Associated Proteins , 2012, PloS one.

[71]  S. Winder,et al.  A new twist to coiled coil , 2012, FEBS letters.

[72]  F. Sbrana,et al.  Microtubules Underlie Dysfunction in Duchenne Muscular Dystrophy , 2012, Science Signaling.

[73]  S. Schenk,et al.  NAD(+)/NADH and skeletal muscle mitochondrial adaptations to exercise. , 2012, American journal of physiology. Endocrinology and metabolism.

[74]  M. Young,et al.  Biglycan: a promising new therapeutic for neuromuscular and musculoskeletal diseases. , 2012, Current opinion in genetics & development.

[75]  G. McConell,et al.  Skeletal muscle nitric oxide signaling and exercise: a focus on glucose metabolism. , 2012, American journal of physiology. Endocrinology and metabolism.

[76]  S. Matecki,et al.  AMPK activation stimulates autophagy and ameliorates muscular dystrophy in the mdx mouse diaphragm. , 2012, The American journal of pathology.

[77]  F. Leturcq,et al.  Variable phenotype of del45-55 Becker patients correlated with nNOSμ mislocalization and RYR1 hypernitrosylation. , 2012, Human molecular genetics.

[78]  E. Clementi,et al.  Nitric Oxide in Myogenesis and Therapeutic Muscle Repair , 2012, Molecular Neurobiology.

[79]  L. Schaefer,et al.  Biglycan: a multivalent proteoglycan providing structure and signals. , 2012, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[80]  Jamie L. Marshall,et al.  Dystrophin and utrophin expression require sarcospan: loss of α7 integrin exacerbates a newly discovered muscle phenotype in sarcospan-null mice. , 2012, Human Molecular Genetics.

[81]  E. Mercuri,et al.  The ever‐expanding spectrum of congenital muscular dystrophies , 2012, Annals of neurology.

[82]  Kevin M Flanigan,et al.  The Muscular Dystrophies , 1999, Seminars in Neurology.

[83]  Jamie L. Marshall,et al.  Sarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration , 2012, The Journal of cell biology.

[84]  Xianhua Wang,et al.  Recombinant MG53 Protein Modulates Therapeutic Cell Membrane Repair in Treatment of Muscular Dystrophy , 2012, Science Translational Medicine.

[85]  D. Allen,et al.  Pathways of Ca²⁺ entry and cytoskeletal damage following eccentric contractions in mouse skeletal muscle. , 2012, Journal of applied physiology.

[86]  Elaine Minatel,et al.  Ascorbic acid protects the diaphragm muscle against myonecrosis in mdx mice. , 2012, Nutrition.

[87]  J. Mendell,et al.  Emerging drugs for Duchenne muscular dystrophy , 2012, Expert opinion on emerging drugs.

[88]  J. Sanes,et al.  Interaction of α-Catulin with Dystrobrevin Contributes to Integrity of Dystrophin Complex in Muscle* , 2012, The Journal of Biological Chemistry.

[89]  P. Muñoz-Cánoves,et al.  Amelioration of Duchenne muscular dystrophy in mdx mice by elimination of matrix-associated fibrin-driven inflammation coupled to the αMβ2 leukocyte integrin receptor. , 2012, Human molecular genetics.

[90]  T. Molinski,et al.  Increased Resting Intracellular Calcium Modulates NF-κB-dependent Inducible Nitric-oxide Synthase Gene Expression in Dystrophic mdx Skeletal Myotubes* , 2012, The Journal of Biological Chemistry.

[91]  Kay E. Davies,et al.  Hsp72 preserves muscle function and slows progression of severe muscular dystrophy , 2012, Nature.

[92]  B. Allard,et al.  Sarcoplasmic reticulum Ca2+ permeation explored from the lumen side in mdx muscle fibers under voltage control , 2012, The Journal of general physiology.

[93]  O. Dorchies,et al.  Quantitative evaluation of the beneficial effects in the mdx mouse of epigallocatechin gallate, an antioxidant polyphenol from green tea , 2012, Histochemistry and Cell Biology.

[94]  A. Nalini,et al.  Oxidative Damage in Muscular Dystrophy Correlates with the Severity of the Pathology: Role of Glutathione Metabolism , 2012, Neurochemical Research.

[95]  E. Hoffman,et al.  Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies , 2012, Mammalian Genome.

[96]  H. Brenner,et al.  Neuregulin/ErbB regulate neuromuscular junction development by phosphorylation of α-dystrobrevin , 2011, The Journal of cell biology.

[97]  P. Sestili,et al.  Reactive Oxygen Species in Skeletal Muscle Signaling , 2011, Journal of signal transduction.

[98]  R. Goldschmeding,et al.  CTGF/CCN‐2 over‐expression can directly induce features of skeletal muscle dystrophy , 2011, The Journal of pathology.

[99]  W. Pratt,et al.  Modulation of Heme/Substrate Binding Cleft of Neuronal Nitric-oxide Synthase (nNOS) Regulates Binding of Hsp90 and Hsp70 Proteins and nNOS Ubiquitination* , 2011, The Journal of Biological Chemistry.

[100]  Masaaki Komatsu,et al.  Autophagy: Renovation of Cells and Tissues , 2011, Cell.

[101]  Angela Feechan,et al.  S-nitrosylation of NADPH oxidase regulates cell death in plant immunity , 2011, Nature.

[102]  J. Ervasti,et al.  Transgenic overexpression of γ-cytoplasmic actin protects against eccentric contraction-induced force loss in mdx mice , 2011, Skeletal Muscle.

[103]  J. Tidball,et al.  Neuronal Nitric Oxide Synthase-Rescue of Dystrophin/Utrophin Double Knockout Mice does not Require nNOS Localization to the Cell Membrane , 2011, PloS one.

[104]  Joe N. Kornegay,et al.  Chronic Administration of a Leupeptin-Derived Calpain Inhibitor Fails to Ameliorate Severe Muscle Pathology in a Canine Model of Duchenne Muscular Dystrophy , 2011, Front. Pharmacol..

[105]  Christopher W Ward,et al.  X-ROS Signaling: Rapid Mechano-Chemo Transduction in Heart , 2011, Science.

[106]  C. Hague,et al.  Syntrophin isoforms play specific functional roles in the α1D-adrenergic receptor/DAPC signalosome. , 2011, Biochemical and biophysical research communications.

[107]  J. Stamler,et al.  Oxygen-coupled redox regulation of the skeletal muscle ryanodine receptor-Ca2+ release channel by NADPH oxidase 4 , 2011, Proceedings of the National Academy of Sciences.

[108]  P. Robbins,et al.  Systemic delivery of NEMO binding domain/IKKγ inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology , 2011, Neurobiology of Disease.

[109]  D. Duan,et al.  iNOS Ablation Does Not Improve Specific Force of the Extensor Digitorum Longus Muscle in Dystrophin-Deficient mdx4cv Mice , 2011, PloS one.

[110]  S. Messina,et al.  Activation of NF-kB pathway in Duchenne muscular dystrophy: relation to age , 2011, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[111]  S. Head,et al.  The role of branched fibres in the pathogenesis of Duchenne muscular dystrophy , 2011, Experimental physiology.

[112]  K. Davies,et al.  Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse , 2011, PloS one.

[113]  C. Mann,et al.  Aberrant repair and fibrosis development in skeletal muscle , 2011, Skeletal Muscle.

[114]  P. Rosenberg,et al.  The role of store-operated calcium influx in skeletal muscle signaling. , 2011, Cell calcium.

[115]  G. Lamb,et al.  Acute effects of reactive oxygen and nitrogen species on the contractile function of skeletal muscle , 2011, The Journal of physiology.

[116]  T. L. Dutka,et al.  Modulation of contractile apparatus Ca2+ sensitivity and disruption of excitation–contraction coupling by S‐nitrosoglutathione in rat muscle fibres , 2011, The Journal of physiology.

[117]  C. Kee,et al.  Myocilin Interacts with Syntrophins and Is Member of Dystrophin-associated Protein Complex* , 2011, The Journal of Biological Chemistry.

[118]  T. Crawford,et al.  Loss of sarcolemmal nNOS is common in acquired and inherited neuromuscular disorders , 2011, Neurology.

[119]  R. Hajjar,et al.  Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle. , 2011, The Journal of clinical investigation.

[120]  J. Faulkner,et al.  Lateral transmission of force is impaired in skeletal muscles of dystrophic mice and very old rats , 2011, The Journal of physiology.

[121]  Karla P. García-Pelagio,et al.  Biomechanics of the sarcolemma and costameres in single skeletal muscle fibers from normal and dystrophin-null mice , 2011, Journal of Muscle Research and Cell Motility.

[122]  P. Yurchenco Basement membranes: cell scaffoldings and signaling platforms. , 2011, Cold Spring Harbor perspectives in biology.

[123]  J. Selsby Increased catalase expression improves muscle function in mdx mice , 2011, Experimental physiology.

[124]  Michael A. Freitas,et al.  Peptide-Based Inhibition of NF-κB Rescues Diaphragm Muscle Contractile Dysfunction in a Murine Model of Duchenne Muscular Dystrophy , 2011, Molecular medicine.

[125]  D. Duan,et al.  Nitrosative stress elicited by nNOSµ delocalization inhibits muscle force in dystrophin‐null mice , 2011, Journal of Pathology.

[126]  J. Fallon,et al.  Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice , 2010, Proceedings of the National Academy of Sciences.

[127]  S. Delp,et al.  Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice , 2010, Cell.

[128]  D. Allen,et al.  Skeletal Muscle NADPH Oxidase Is Increased and Triggers Stretch-Induced Damage in the mdx Mouse , 2010, PloS one.

[129]  Jeong-A Lim,et al.  α-Syntrophin Modulates Myogenin Expression in Differentiating Myoblasts , 2010, PloS one.

[130]  Jay J. Han,et al.  The 6‐minute walk test in Duchenne/Becker muscular dystrophy: Longitudinal observations , 2010, Muscle & nerve.

[131]  P. Currie,et al.  Dystrophin-deficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology , 2010, Neuromuscular Disorders.

[132]  L. Langeberg,et al.  α-Dystrobrevin-1 recruits α-catulin to the α1D-adrenergic receptor/dystrophin-associated protein complex signalosome , 2010, Proceedings of the National Academy of Sciences.

[133]  H. Sweeney,et al.  Leupeptin-based inhibitors do not improve the mdx phenotype. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[134]  P. Muñoz-Cánoves,et al.  Regulation and dysregulation of fibrosis in skeletal muscle. , 2010, Experimental cell research.

[135]  J. Beavo,et al.  Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy , 2010, Proceedings of the National Academy of Sciences.

[136]  J. Mendell,et al.  Dystrophin immunity in Duchenne's muscular dystrophy. , 2010, The New England journal of medicine.

[137]  C. Ward,et al.  Mitochondrial redox potential during contraction in single intact muscle fibers , 2010, Muscle & nerve.

[138]  Jian Yang,et al.  The ß subunit of voltage-gated Ca2+ channels. , 2010, Physiological reviews.

[139]  Yu. V. Bodrov,et al.  β2-Syntrophin Is a Cdk5 Substrate That Restrains the Motility of Insulin Secretory Granules , 2010, PloS one.

[140]  S. Winder,et al.  Dystrophin: more than just the sum of its parts. , 2010, Biochimica et biophysica acta.

[141]  Lan-Fang Zhou,et al.  Targeting Fibrosis in Duchenne Muscular Dystrophy , 2010, Journal of neuropathology and experimental neurology.

[142]  A. Varki,et al.  A Human-Specific Deletion in Mouse Cmah Increases Disease Severity in the mdx Model of Duchenne Muscular Dystrophy , 2010, Science Translational Medicine.

[143]  R. Bloch,et al.  Erratum to: Differential distribution of dystrophin and β-spectrin at the sarcolemma of fast twitch skeletal muscle fibers , 2010, Journal of Muscle Research and Cell Motility.

[144]  F. von Wegner,et al.  Upregulation of store-operated Ca2+ entry in dystrophic mdx mouse muscle. , 2010, American journal of physiology. Cell physiology.

[145]  R. Penner,et al.  Activation of store-operated I(CRAC) by hydrogen peroxide. , 2010, Cell calcium.

[146]  B. Launikonis,et al.  Toward the roles of store-operated Ca2+ entry in skeletal muscle , 2010, Pflügers Archiv - European Journal of Physiology.

[147]  K. Davies,et al.  Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin , 2010, Journal of Cell Science.

[148]  J. Kirschner,et al.  Elevated satellite cell number in Duchenne muscular dystrophy , 2010, Cell and Tissue Research.

[149]  S. Head Branched fibres in old dystrophic mdx muscle are associated with mechanical weakening of the sarcolemma, abnormal Ca2+ transients and a breakdown of Ca2+ homeostasis during fatigue , 2010, Experimental physiology.

[150]  J. Chamberlain,et al.  The Polyproline Site in Hinge 2 Influences the Functional Capacity of Truncated Dystrophins , 2010, PLoS genetics.

[151]  Paul L Huang,et al.  Golgi and sarcolemmal neuronal NOS differentially regulate contraction-induced fatigue and vasoconstriction in exercising mouse skeletal muscle. , 2010, The Journal of clinical investigation.

[152]  A. Lambacher,et al.  Integrin-Linked Kinase Controls Microtubule Dynamics Required for Plasma Membrane Targeting of Caveolae , 2010, Developmental cell.

[153]  S. Schiaffino,et al.  Regeneration of mammalian skeletal muscle. Basic mechanisms and clinical implications. , 2010, Current pharmaceutical design.

[154]  C. Garbe,et al.  Microarchitecture is severely compromised but motor protein function is preserved in dystrophic mdx skeletal muscle. , 2010, Biophysical journal.

[155]  C. Ingalls,et al.  Junctophilin damage contributes to early strength deficits and EC coupling failure after eccentric contractions. , 2010, American journal of physiology. Cell physiology.

[156]  F. Sotgia,et al.  Caveolinopathies: from the biology of caveolin-3 to human diseases , 2010, European Journal of Human Genetics.

[157]  G. Hause,et al.  The shape of caveolae is omega-like after glutaraldehyde fixation and cup-like after cryofixation , 2010, Histochemistry and Cell Biology.

[158]  C. Cognard,et al.  Regulation by scaffolding proteins of canonical transient receptor potential channels in striated muscle , 2009, Journal of Muscle Research and Cell Motility.

[159]  S. Gibson,et al.  TAPP2 links phosphoinositide 3-kinase signaling to B-cell adhesion through interaction with the cytoskeletal protein utrophin: expression of a novel cell adhesion-promoting complex in B-cell leukemia. , 2009, Blood.

[160]  B. Aronow,et al.  Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanism , 2009, Proceedings of the National Academy of Sciences.

[161]  M. Jackson Redox regulation of adaptive responses in skeletal muscle to contractile activity. , 2009, Free radical biology & medicine.

[162]  C. Cognard,et al.  Regulation of TRPC1 and TRPC4 Cation Channels Requires an α1-Syntrophin-dependent Complex in Skeletal Mouse Myotubes* , 2009, The Journal of Biological Chemistry.

[163]  J. Tidball,et al.  Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophy. , 2009, Human molecular genetics.

[164]  D. Sandonà,et al.  Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects , 2009, Expert Reviews in Molecular Medicine.

[165]  C. Ward,et al.  Malformed mdx myofibers have normal cytoskeletal architecture yet altered EC coupling and stress-induced Ca2+ signaling. , 2009, American journal of physiology. Cell physiology.

[166]  Jill L. Humston,et al.  Dystrophin is a microtubule-associated protein , 2009, The Journal of cell biology.

[167]  F. Leturcq,et al.  Endomysial Fibrosis in Duchenne Muscular Dystrophy: A Marker of Poor Outcome Associated With Macrophage Alternative Activation , 2009, Journal of neuropathology and experimental neurology.

[168]  A. Suzuki,et al.  Intracellular polarity protein PAR‐1 regulates extracellular laminin assembly by regulating the dystroglycan complex , 2009, Genes to cells : devoted to molecular & cellular mechanisms.

[169]  S. Hardy,et al.  Mapping of the lipid-binding and stability properties of the central rod domain of human dystrophin. , 2009, Journal of molecular biology.

[170]  E. Hoffman,et al.  Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta. , 2009, The Journal of clinical investigation.

[171]  J. Rabek,et al.  Oxidative modification and aggregation of creatine kinase from aged mouse skeletal muscle , 2009, Aging.

[172]  D. Burkin,et al.  Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy , 2009, Proceedings of the National Academy of Sciences.

[173]  A. Brancaccio,et al.  Functional diversity of dystroglycan. , 2009, Matrix biology : journal of the International Society for Matrix Biology.

[174]  G. Lamb,et al.  Involvement of calpains in Ca2+-induced disruption of excitation-contraction coupling in mammalian skeletal muscle fibers. , 2009, American journal of physiology. Cell physiology.

[175]  H. Jarrett,et al.  Dystrophin glycoprotein complex‐associated Gβγ subunits activate phosphatidylinositol‐3‐kinase/Akt signaling in skeletal muscle in a laminin‐dependent manner , 2009, Journal of cellular physiology.

[176]  M. Nowycky,et al.  Reciprocal amplification of ROS and Ca2+ signals in stressed mdx dystrophic skeletal muscle fibers , 2009, Pflügers Archiv - European Journal of Physiology.

[177]  G. Lamb,et al.  Plasma membrane removal in rat skeletal muscle fibers reveals caveolin-3 hot-spots at the necks of transverse tubules. , 2009, Experimental cell research.

[178]  G. Lamb,et al.  Endogenous Calpain-3 Activation Is Primarily Governed by Small Increases in Resting Cytoplasmic [Ca2+] and Is Not Dependent on Stretch* , 2009, Journal of Biological Chemistry.

[179]  D. Duan,et al.  Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. , 2009, The Journal of clinical investigation.

[180]  Yuji Arai,et al.  Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models. , 2009, Human molecular genetics.

[181]  Gregory Q. Wallace,et al.  Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies. , 2009, Annual review of physiology.

[182]  S. Matecki,et al.  Hypernitrosylated ryanodine receptor/calcium release channels are leaky in dystrophic muscle , 2009, Nature Medicine.

[183]  M. Bahlo,et al.  Mutations in contactin-1, a neural adhesion and neuromuscular junction protein, cause a familial form of lethal congenital myopathy. , 2008, American journal of human genetics.

[184]  G. McConell,et al.  Potential Role of Nitric Oxide in Contraction-stimulated Glucose Uptakeand Mitochondrial Biogenesis in Skeletal Muscle Does No/nos Regulate Contraction-stimulated Glucose Uptake? , 2022 .

[185]  K. Bushby,et al.  Sarcoglycanopathies: Can muscle immunoanalysis predict the genotype? , 2008, Neuromuscular Disorders.

[186]  S. Winder,et al.  Dystroglycan, Tks5 and Src Mediated Assembly of Podosomes in Myoblasts , 2008, PloS one.

[187]  Jamie L. Marshall,et al.  Sarcospan reduces dystrophic pathology: stabilization of the utrophin–glycoprotein complex , 2008, The Journal of cell biology.

[188]  S. Baylor,et al.  Comparison of the myoplasmic calcium transient elicited by an action potential in intact fibres of mdx and normal mice , 2008, The Journal of physiology.

[189]  O. Halevy,et al.  Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone , 2008, Neuromuscular Disorders.

[190]  G. Kroemer,et al.  Autophagic cell death: the story of a misnomer , 2008, Nature Reviews Molecular Cell Biology.

[191]  A. Uezumi,et al.  Suppression of macrophage functions impairs skeletal muscle regeneration with severe fibrosis. , 2008, Experimental cell research.

[192]  J. Chamberlain,et al.  Functional Deficits in nNOSμ-Deficient Skeletal Muscle: Myopathy in nNOS Knockout Mice , 2008, PloS one.

[193]  R. Dirksen,et al.  Differential dependence of store‐operated and excitation‐coupled Ca2+ entry in skeletal muscle on STIM1 and Orai1 , 2008, The Journal of physiology.

[194]  C. Moorwood,et al.  Syncoilin, an intermediate filament-like protein linked to the dystrophin associated protein complex in skeletal muscle , 2008, Cellular and Molecular Life Sciences.

[195]  D. Thedens,et al.  Sarcolemma-localized nNOS is required to maintain activity after mild exercise , 2008, Nature.

[196]  R. Grange,et al.  Endurance capacity in maturing mdx mice is markedly enhanced by combined voluntary wheel running and green tea extract. , 2008, Journal of applied physiology.

[197]  A. Moss,et al.  α-1-Syntrophin Mutation and the Long-QT Syndrome: A Disease of Sodium Channel Disruption , 2008, Circulation. Arrhythmia and electrophysiology.

[198]  D. Tester,et al.  Syntrophin mutation associated with long QT syndrome through activation of the nNOS–SCN5A macromolecular complex , 2008, Proceedings of the National Academy of Sciences.

[199]  C. Hague,et al.  Blood Pressure Is Regulated by an α1D-Adrenergic Receptor/Dystrophin Signalosome* , 2008, Journal of Biological Chemistry.

[200]  D. Allen,et al.  TRPC1 binds to caveolin-3 and is regulated by Src kinase – role in Duchenne muscular dystrophy , 2008, Journal of Cell Science.

[201]  J. Faulkner,et al.  DIAPHRAGM MUSCLE STRIP PREPARATION FOR EVALUATION OF GENE THERAPIES IN mdx MICE , 2008, Clinical and experimental pharmacology & physiology.

[202]  P. Carmeliet,et al.  Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway. , 2008, Genes & development.

[203]  J. Ervasti,et al.  Skeletal Muscle-Specific Ablation of γcyto-Actin Does Not Exacerbate the mdx Phenotype , 2008, PloS one.

[204]  G. Buonocore,et al.  Isoprostanes in dystrophinopathy: Evidence of increased oxidative stress , 2008, Brain and Development.

[205]  C. Des Rosiers,et al.  Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency , 2008, Proceedings of the National Academy of Sciences.

[206]  Ning Wang,et al.  Rapid signal transduction in living cells is a unique feature of mechanotransduction , 2008, Proceedings of the National Academy of Sciences.

[207]  J. Chamberlain,et al.  Emergent dilated cardiomyopathy caused by targeted repair of dystrophic skeletal muscle. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[208]  D. Sherman,et al.  The ABCA1 cholesterol transporter associates with one of two distinct dystrophin‐based scaffolds in Schwann cells , 2008, Glia.

[209]  D. Allen,et al.  N‐Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice , 2008, The Journal of physiology.

[210]  O. Halevy,et al.  Functional resolution of fibrosis in mdx mouse dystrophic heart and skeletal muscle by halofuginone. , 2008, American journal of physiology. Heart and circulatory physiology.

[211]  D. Felsenberg,et al.  Ryanodine receptor type-1 (RyR1) expression and protein S-nitrosylation pattern in human soleus myofibres following bed rest and exercise countermeasure , 2008, Histochemistry and Cell Biology.

[212]  S. Reiken,et al.  Remodeling of ryanodine receptor complex causes “leaky” channels: A molecular mechanism for decreased exercise capacity , 2008, Proceedings of the National Academy of Sciences.

[213]  G. Truskey,et al.  Mice Lacking Homer 1 Exhibit a Skeletal Myopathy Characterized by Abnormal Transient Receptor Potential Channel Activity , 2008, Molecular and Cellular Biology.

[214]  V. A. Villar,et al.  Lipid Rafts Keep NADPH Oxidase in the Inactive State in Human Renal Proximal Tubule Cells , 2008, Hypertension.

[215]  D. Claflin,et al.  Direct observation of failing fibers in muscles of dystrophic mice provides mechanistic insight into muscular dystrophy. , 2008, American journal of physiology. Cell physiology.

[216]  A. Brunelle,et al.  Lipid mapping in human dystrophic muscle by cluster-time-of-flight secondary ion mass spectrometry imaging Published, JLR Papers in Press, November 17, 2007. , 2008, Journal of Lipid Research.

[217]  R. Brandes,et al.  Regulation of proliferation of skeletal muscle precursor cells by NADPH oxidase. , 2008, Antioxidants & redox signaling.

[218]  M. Kirkham,et al.  PTRF-Cavin, a Conserved Cytoplasmic Protein Required for Caveola Formation and Function , 2008, Cell.

[219]  M. Nowycky,et al.  Reactive oxygen species contribute to Ca2+ signals produced by osmotic stress in mouse skeletal muscle fibres , 2008, The Journal of physiology.

[220]  Kendra Anderson,et al.  Differential targeting of nNOS and AQP4 to dystrophin-deficient sarcolemma by membrane-directed α-dystrobrevin , 2008, Journal of Cell Science.

[221]  M. Omary,et al.  Absence of keratin 19 in mice causes skeletal myopathy with mitochondrial and sarcolemmal reorganization , 2007, Journal of Cell Science.

[222]  J. Chamberlain,et al.  rAAV6‐Microdystrophin Rescues Aberrant Golgi Complex Organization in mdx Skeletal Muscles , 2007, Traffic.

[223]  Y. Itoyama,et al.  NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. , 2007, The Journal of clinical investigation.

[224]  A. Meixner,et al.  S-nitrosylation of microtubule-associated protein 1B mediates nitric-oxide-induced axon retraction , 2007, Nature Cell Biology.

[225]  J. Morley,et al.  Branched fibers in dystrophic mdx muscle are associated with a loss of force following lengthening contractions. , 2007, American journal of physiology. Cell physiology.

[226]  B. Saltin Exercise hyperaemia: magnitude and aspects on regulation in humans , 2007, The Journal of physiology.

[227]  D. Allen,et al.  The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice. , 2007, American journal of physiology. Heart and circulatory physiology.

[228]  T. Südhof,et al.  Primary Role of Functional Ischemia, Quantitative Evidence for the Two-Hit Mechanism, and Phosphodiesterase-5 Inhibitor Therapy in Mouse Muscular Dystrophy , 2007, PloS one.

[229]  K. Krause,et al.  NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. , 2007, The Biochemical journal.

[230]  J. Gillis,et al.  In situ measurements of calpain activity in isolated muscle fibres from normal and dystrophin‐lacking mdx mice , 2007, The Journal of physiology.

[231]  J. Lambeth Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. , 2007, Free radical biology & medicine.

[232]  David P. Corey,et al.  TRP channels in mechanosensation: direct or indirect activation? , 2007, Nature Reviews Neuroscience.

[233]  S. Gee,et al.  Morphological changes and spatial regulation of diacylglycerol kinase-zeta, syntrophins, and Rac1 during myoblast fusion. , 2007, Cell motility and the cytoskeleton.

[234]  B. Nico,et al.  Role of tumour necrosis factor α, but not of cyclo‐oxygenase‐2‐derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach , 2007, Neuropathology and applied neurobiology.

[235]  Meenal Patel,et al.  PTC124 targets genetic disorders caused by nonsense mutations , 2007, Nature.

[236]  F. Sachs,et al.  Mechanosensitive channel properties and membrane mechanics in mouse dystrophic myotubes , 2007, The Journal of physiology.

[237]  K. Davies,et al.  Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with β-dystroglycan , 2007, The Journal of cell biology.

[238]  J. Percival,et al.  Golgi Complex Organization in Skeletal Muscle: A Role for Golgi‐Mediated Glycosylation in Muscular Dystrophies? , 2007, Traffic.

[239]  Angela K. Peter,et al.  Structural and functional analysis of the sarcoglycan-sarcospan subcomplex. , 2007, Experimental cell research.

[240]  E. McNally,et al.  Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy. , 2007, Trends in cardiovascular medicine.

[241]  F. Rivier,et al.  Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice. , 2007, The American journal of pathology.

[242]  Baohua Yang,et al.  TNF-α potentiates protein-tyrosine nitration through activation of NADPH oxidase and eNOS localized in membrane rafts and caveolae of bovine aortic endothelial cells , 2007 .

[243]  C. Cognard,et al.  Regulation of capacitative calcium entries by α1‐syntrophin: association of TRPC1 with dystrophin complex and the PDZ domain of α1‐syntrophin , 2007 .

[244]  Nicholas L. Cianciola,et al.  The intermediate filament protein, synemin, is an AKAP in the heart. , 2006, Archives of biochemistry and biophysics.

[245]  D. Allen,et al.  Streptomycin reduces stretch-induced membrane permeability in muscles from mdx mice , 2006, Neuromuscular Disorders.

[246]  B. Wong,et al.  Poloxamer 188 failed to prevent exercise-induced membrane breakdown in mdx skeletal muscle fibers , 2006, Neuromuscular Disorders.

[247]  M. Rafii,et al.  Biglycan binds to α‐ and γ‐sarcoglycan and regulates their expression during development , 2006 .

[248]  M. Grounds,et al.  Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFα function with Etanercept in mdx mice , 2006, Neuromuscular Disorders.

[249]  G. Lamb,et al.  Ca2+ activation of diffusible and bound pools of μ‐calpain in rat skeletal muscle , 2006, The Journal of physiology.

[250]  J. Percival,et al.  γ-Syntrophin scaffolding is spatially and functionally distinct from that of the α/β syntrophins , 2006 .

[251]  O. Hamill,et al.  Twenty odd years of stretch-sensitive channels , 2006, Pflügers Archiv.

[252]  Dean P. Jones Redefining oxidative stress. , 2006, Antioxidants & redox signaling.

[253]  O. Dorchies,et al.  Ca2+-independent phospholipase A2 enhances store-operated Ca2+ entry in dystrophic skeletal muscle fibers , 2006, Journal of Cell Science.

[254]  P. Insel,et al.  Microtubules and Actin Microfilaments Regulate Lipid Raft/Caveolae Localization of Adenylyl Cyclase Signaling Components* , 2006, Journal of Biological Chemistry.

[255]  C. Hidalgo,et al.  A Transverse Tubule NADPH Oxidase Activity Stimulates Calcium Release from Isolated Triads via Ryanodine Receptor Type 1 S -Glutathionylation* , 2006, Journal of Biological Chemistry.

[256]  J. Ervasti,et al.  Cytoplasmic gamma-actin is not required for skeletal muscle development but its absence leads to a progressive myopathy. , 2006, Developmental cell.

[257]  J. Lebacq,et al.  Functional role of store‐operated and stretch‐activated channels in murine adult skeletal muscle fibres , 2006, The Journal of physiology.

[258]  M. Rafii,et al.  Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[259]  J. Heighway,et al.  Over-expression of Microspan, a novel component of the sarcoplasmic reticulum, causes severe muscle pathology with triad abnormalities , 2006, Journal of Muscle Research & Cell Motility.

[260]  D. Allen,et al.  MUSCLE DAMAGE IN MDX (DYSTROPHIC) MICE: ROLE OF CALCIUM AND REACTIVE OXYGEN SPECIES , 2006, Clinical and experimental pharmacology & physiology.

[261]  C. Bönnemann,et al.  Congenital muscular dystrophies and the extracellular matrix. , 2006, Seminars in pediatric neurology.

[262]  M. Boppart,et al.  α7β1-Integrin regulates mechanotransduction and prevents skeletal muscle injury , 2006 .

[263]  J. Fritschy,et al.  Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue , 2006, Cellular and Molecular Life Sciences CMLS.

[264]  Bogdan Tanasa,et al.  A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function , 2006, Nature.

[265]  L. Lands,et al.  Sarcolemmal damage in dystrophin deficiency is modulated by synergistic interactions between mechanical and oxidative/nitrosative stresses. , 2006, The American journal of pathology.

[266]  A. Bitto,et al.  Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice. , 2006, The American journal of pathology.

[267]  S. Snyder,et al.  Alternatively spliced neuronal nitric oxide synthase mediates penile erection. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[268]  H. Jarrett,et al.  Binding of laminin α1-chain LG4-5 domain to α-dystroglycan causes tyrosine phosphorylation of syntrophin to initiate Rac1 signaling , 2006 .

[269]  O. Dorchies,et al.  Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy. , 2006, American journal of physiology. Cell physiology.

[270]  L. Birnbaumer,et al.  Role of Src in C3 transient receptor potential channel function and evidence for a heterogeneous makeup of receptor- and store-operated Ca2+ entry channels. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[271]  Francesco Muntoni,et al.  Syncoilin upregulation in muscle of patients with neuromuscular disease , 2005, Muscle & nerve.

[272]  M. Freeman,et al.  Purification of ATP-binding Cassette Transporter A1 and Associated Binding Proteins Reveals the Importance of β1-Syntrophin in Cholesterol Efflux* , 2005, Journal of Biological Chemistry.

[273]  M. DiFranco,et al.  Propagation in the transverse tubular system and voltage dependence of calcium release in normal and mdx mouse muscle fibres , 2005, The Journal of physiology.

[274]  T. Sasaoka,et al.  Molecular and cell biology of the sarcoglycan complex , 2005, Muscle & nerve.

[275]  D. Discher,et al.  Molecular extensibility of mini-dystrophins and a dystrophin rod construct. , 2005, Journal of molecular biology.

[276]  Y. W. Chen,et al.  Early onset of inflammation and later involvement of TGFβ in Duchenne muscular dystrophy , 2005, Neurology.

[277]  Andrea O'Neill,et al.  Specific interaction of the actin-binding domain of dystrophin with intermediate filaments containing keratin 19. , 2005, Molecular biology of the cell.

[278]  C. Kung,et al.  A possible unifying principle for mechanosensation , 2005, Nature.

[279]  Thomas W Prior,et al.  Experience and strategy for the molecular testing of Duchenne muscular dystrophy. , 2005, The Journal of molecular diagnostics : JMD.

[280]  E. Kudryashova,et al.  Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway. , 2005, Human molecular genetics.

[281]  Shuo Luo,et al.  α-Syntrophin regulates ARMS localization at the neuromuscular junction and enhances EphA4 signaling in an ARMS-dependent manner , 2005, The Journal of cell biology.

[282]  S. Carbonetto,et al.  Evidence That Dystroglycan Is Associated with Dynamin and Regulates Endocytosis* , 2005, Journal of Biological Chemistry.

[283]  F. Salvatore,et al.  Analysis of dystrophin gene deletions indicates that the hinge III region of the protein correlates with disease severity. , 2005, Annals of human genetics.

[284]  Jianjie Ma,et al.  Uncontrolled calcium sparks act as a dystrophic signal for mammalian skeletal muscle , 2005, Nature Cell Biology.

[285]  F. Salvatore,et al.  Analysis of Dystrophin Gene Deletions Indicates that the Hinge III Region of the Protein Correlates with Disease Severity , 2005 .

[286]  K. North,et al.  The Syntrophin-Dystrobrevin Subcomplex in Human Neuromuscular Disorders , 2005, Journal of neuropathology and experimental neurology.

[287]  W. Catterall,et al.  Convergent regulation of skeletal muscle Ca2+ channels by dystrophin, the actin cytoskeleton, and cAMP-dependent protein kinase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[288]  Yuka Itoh,et al.  The utrophin promoter A drives high expression of the transgenic LacZ gene in liver, testis, colon, submandibular gland, and small intestine , 2005, The journal of gene medicine.

[289]  A. Kurosky,et al.  TRPC1 forms the stretch-activated cation channel in vertebrate cells , 2005, Nature Cell Biology.

[290]  L. Kunkel Cloning of the DMD Gene , 2005 .

[291]  D. Allen,et al.  Effects of stretch‐activated channel blockers on [Ca2+]i and muscle damage in the mdx mouse , 2005, The Journal of physiology.

[292]  D. Paulin,et al.  Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle. , 2004, Experimental cell research.

[293]  M. Lisanti,et al.  Role of caveolae and caveolins in health and disease. , 2004, Physiological reviews.

[294]  F. Muntoni,et al.  Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions , 2004, Neuropathology and applied neurobiology.

[295]  K. Ohlendieck,et al.  Subproteomics analysis of Ca2+‐binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle , 2004 .

[296]  J. Tidball,et al.  Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. , 2004, Molecular genetics and metabolism.

[297]  P. Kofuji,et al.  The Potassium Channel Kir4.1 Associates with the Dystrophin-Glycoprotein Complex via α-Syntrophin in Glia* , 2004, Journal of Biological Chemistry.

[298]  J. Yates,et al.  Protein Trafficking and Anchoring Complexes Revealed by Proteomic Analysis of Inward Rectifier Potassium Channel (Kir2.x)-associated Proteins* , 2004, Journal of Biological Chemistry.

[299]  M. DiFranco,et al.  The action potential‐evoked sarcoplasmic reticulum calcium release is impaired in mdx mouse muscle fibres , 2004, The Journal of physiology.

[300]  Andrew Leask,et al.  TGF‐β signaling and the fibrotic response , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[301]  K. Shitara,et al.  α1-Syntrophin Modulates Turnover of ABCA1* , 2004, Journal of Biological Chemistry.

[302]  B. Lévy,et al.  Absence of Dystrophin in Mice Reduces NO-Dependent Vascular Function and Vascular Density: Total Recovery After a Treatment with the Aminoglycoside Gentamicin , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[303]  M. Grounds,et al.  Anti‐TNFα (Remicade®) therapy protects dystrophic skeletal muscle from necrosis , 2004 .

[304]  Yuko Sato,et al.  Identification of Caveolin-1-interacting Sites in Neuronal Nitric-oxide Synthase , 2004, Journal of Biological Chemistry.

[305]  B. van Deurs,et al.  The phagocyte NADPH oxidase depends on cholesterol‐enriched membrane microdomains for assembly , 2004, The EMBO journal.

[306]  P. Mcneil,et al.  Plasma membrane disruption: repair, prevention, adaptation. , 2003, Annual review of cell and developmental biology.

[307]  M. Topham,et al.  Diacylglycerol kinase-zeta localization in skeletal muscle is regulated by phosphorylation and interaction with syntrophins. , 2003, Molecular biology of the cell.

[308]  M. Shigekawa,et al.  TRPV2 Is a Component of Osmotically Sensitive Cation Channels in Murine Aortic Myocytes , 2003, Circulation research.

[309]  Joseph P. Yuan,et al.  Homer Binds TRPC Family Channels and Is Required for Gating of TRPC1 by IP3 Receptors , 2003, Cell.

[310]  J. Gutkind,et al.  Rac1 Function Is Required for Src-induced Transformation , 2003, Journal of Biological Chemistry.

[311]  S. Miyamoto,et al.  Initiation and Transduction of Stretch-induced RhoA and Rac1 Activation through Caveolae , 2003, Journal of Biological Chemistry.

[312]  D. E. Goll,et al.  The calpain system. , 2003, Physiological reviews.

[313]  M. Wilson,et al.  Localization of phospho-beta-dystroglycan (pY892) to an intracellular vesicular compartment in cultured cells and skeletal muscle fibers in vivo. , 2003, Biochemistry.

[314]  Steven M. Holland,et al.  Mechanical Stretch Enhances mRNA Expression and Proenzyme Release of Matrix Metalloproteinase‐2 (MMP‐2) via NAD(P)H Oxidase‐Derived Reactive Oxygen Species , 2003, Circulation research.

[315]  E. Schiffrin,et al.  c-Src Induces Phosphorylation and Translocation of p47phox: Role in Superoxide Generation by Angiotensin II in Human Vascular Smooth Muscle Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[316]  Chien-Chang Chen,et al.  Defective membrane repair in dysferlin-deficient muscular dystrophy , 2003, Nature.

[317]  G. Lynch,et al.  Depolarization-induced contraction and SR function in mechanically skinned muscle fibers from dystrophic mdx mice. , 2003, American journal of physiology. Cell physiology.

[318]  J. Ervasti Costameres: the Achilles' Heel of Herculean Muscle* 210 , 2003, The Journal of Biological Chemistry.

[319]  I. Yuhanna,et al.  Vasomodulation by Skeletal Muscle–Derived Nitric Oxide Requires &agr;-Syntrophin–Mediated Sarcolemmal Localization of Neuronal Nitric Oxide Synthase , 2003, Circulation research.

[320]  T. Hashikawa,et al.  Sast124, a novel splice variant of syntrophin-associated serine/threonine kinase (SAST), is specifically localized in the restricted brain regions , 2003, Neuroscience.

[321]  J. Sanes,et al.  Tyrosine-phosphorylated and nonphosphorylated isoforms of α-dystrobrevin , 2003, The Journal of Cell Biology.

[322]  B. Sumpio,et al.  Modulation of vascular smooth muscle cell alignment by cyclic strain is dependent on reactive oxygen species and P38 mitogen-activated protein kinase. , 2003, Journal of vascular surgery.

[323]  Ashok Kumar,et al.  Mechanical stress activates the nuclear factor‐kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[324]  D. Stephenson,et al.  Identification of the coupling between skeletal muscle store-operated Ca2+ entry and the inositol trisphosphate receptor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[325]  Ole Petter Ottersen,et al.  An α-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[326]  Susan C. Brown,et al.  Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle , 2003, Neuromuscular Disorders.

[327]  K. Davies,et al.  Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system. , 2002, Human molecular genetics.

[328]  Colin Chandler,et al.  Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation , 2002, Neuromuscular Disorders.

[329]  M. Brand,et al.  Topology of Superoxide Production from Different Sites in the Mitochondrial Electron Transport Chain* , 2002, The Journal of Biological Chemistry.

[330]  Richard G. W. Anderson,et al.  Dual control of caveolar membrane traffic by microtubules and the actin cytoskeleton , 2002, Journal of Cell Science.

[331]  T. Rando Oxidative Stress and the Pathogenesis of Muscular Dystrophies , 2002, American journal of physical medicine & rehabilitation.

[332]  K. Campbell,et al.  Loss of sarcolemma nNOS in sarcoglycan‐deficient muscle , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[333]  R. Mellgren,et al.  Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology. , 2002, Human molecular genetics.

[334]  H. Debaix,et al.  Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers , 2002, The Journal of cell biology.

[335]  Ying Tang,et al.  Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice. , 2002, Human gene therapy.

[336]  Eric P Hoffman,et al.  Functional characteristics of dystrophic skeletal muscle: insights from animal models. , 2002, Journal of applied physiology.

[337]  C. Huchet-Cadiou,et al.  Sarcoplasmic reticulum function in slow- and fast-twitch skeletal muscles from mdx mice , 2002, Pflügers Archiv.

[338]  Y. Capetanaki,et al.  Sarcolemmal organization in skeletal muscle lacking desmin: evidence for cytokeratins associated with the membrane skeleton at costameres. , 2002, Molecular biology of the cell.

[339]  Paul L Huang,et al.  Deletion of exon 6 of the neuronal nitric oxide synthase gene in mice results in hypogonadism and infertility. , 2002, Endocrinology.

[340]  G. Schmitz,et al.  The carboxyterminus of the ATP-binding cassette transporter A1 interacts with a beta2-syntrophin/utrophin complex. , 2002, Biochemical and biophysical research communications.

[341]  Andrew P. Weir,et al.  Function and genetics of dystrophin and dystrophin-related proteins in muscle. , 2002, Physiological reviews.

[342]  A. Franco-Obregón,et al.  Changes in mechanosensitive channel gating following mechanical stimulation in skeletal muscle myotubes from the mdx mouse , 2002, The Journal of physiology.

[343]  Dongsheng Duan,et al.  Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy , 2002, Nature Medicine.

[344]  Marius Sudol,et al.  The WW domain: linking cell signalling to the membrane cytoskeleton. , 2002, Cellular signalling.

[345]  N. Raben,et al.  Phosphofructokinase deficiency; past, present and future. , 2002, Current molecular medicine.

[346]  M. Bucan,et al.  Running endurance abnormality in mdx mice , 2002, Muscle & nerve.

[347]  S. Newey,et al.  Association of Syncoilin and Desmin , 2002, The Journal of Biological Chemistry.

[348]  S. Hussain,et al.  Molecular characterization of a superoxide-generating NAD(P)H oxidase in the ventilatory muscles. , 2002, American journal of respiratory and critical care medicine.

[349]  M. Grounds,et al.  Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability , 2002, Journal of anatomy.

[350]  B. Firestein,et al.  Binding of Neuronal Nitric-oxide Synthase (nNOS) to Carboxyl-terminal-binding Protein (CtBP) Changes the Localization of CtBP from the Nucleus to the Cytosol , 2001, The Journal of Biological Chemistry.

[351]  F. Sotgia,et al.  Tyrosine phosphorylation of beta-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins. , 2001, Biochemistry.

[352]  P. Agre,et al.  Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[353]  T. Rando Role of nitric oxide in the pathogenesis of muscular dystrophies: A “two hit” hypothesis of the cause of muscle necrosis , 2001, Microscopy research and technique.

[354]  J. Tidball,et al.  A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice , 2001, The Journal of cell biology.

[355]  S. Froehner,et al.  In vivo requirement of the α-syntrophin PDZ domain for the sarcolemmal localization of nNOS and aquaporin-4 , 2001, The Journal of cell biology.

[356]  H. Jarrett,et al.  Mouse alpha1-syntrophin binding to Grb2: further evidence of a role for syntrophin in cell signaling. , 2001, Biochemistry.

[357]  S J Winder,et al.  The interaction of dystrophin with beta-dystroglycan is regulated by tyrosine phosphorylation. , 2001, Cellular signalling.

[358]  J. Faulkner,et al.  Force and power output of fast and slow skeletal muscles from mdx mice 6‐28 months old , 2001, The Journal of physiology.

[359]  M. Solimena,et al.  Dephosphorylation of β2‐syntrophin and Ca2+/μ‐calpain‐mediated cleavage of ICA512 upon stimulation of insulin secretion , 2001, The EMBO journal.

[360]  E. Caler,et al.  Plasma Membrane Repair Is Mediated by Ca2+-Regulated Exocytosis of Lysosomes , 2001, Cell.

[361]  G. Shao,et al.  Prediction of amorphous phase stability in the metal–silicon systems , 2001 .

[362]  J. Engelman,et al.  Caveolin-3 Null Mice Show a Loss of Caveolae, Changes in the Microdomain Distribution of the Dystrophin-Glycoprotein Complex, and T-tubule Abnormalities* , 2001, The Journal of Biological Chemistry.

[363]  Simon C Watkins,et al.  Desmuslin, an intermediate filament protein that interacts with α-dystrobrevin and desmin , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[364]  Y. Ogawa,et al.  Depletion of Ca2+ in the sarcoplasmic reticulum stimulates Ca2+ entry into mouse skeletal muscle fibres , 2001, The Journal of physiology.

[365]  J. Fridén,et al.  Serum creatine kinase level is a poor predictor of muscle function after injury , 2001, Scandinavian journal of medicine & science in sports.

[366]  D. Bredt,et al.  The susceptibility of muscle cells to oxidative stress is independent of nitric oxide synthase expression , 2001, Muscle & nerve.

[367]  C. Ponting,et al.  Syncoilin, a Novel Member of the Intermediate Filament Superfamily That Interacts with α-Dystrobrevin in Skeletal Muscle* , 2001, The Journal of Biological Chemistry.

[368]  J. Fridén,et al.  Eccentric exercise-induced injuries to contractile and cytoskeletal muscle fibre components. , 2001, Acta physiologica Scandinavica.

[369]  M. Reid,et al.  highlighted topics Plasticity in Skeletal, Cardiac, and Smooth Muscle Invited Review: Redox modulation of skeletal muscle contraction: what we know and what we don’t , 2001 .

[370]  C. Cognard,et al.  Cationic channels in normal and dystrophic human myotubes , 2001, Neuromuscular Disorders.

[371]  G. D. Thomas,et al.  Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[372]  F. Sotgia,et al.  Caveolin-3 directly interacts with the C-terminal tail of beta -dystroglycan. Identification of a central WW-like domain within caveolin family members. , 2000, The Journal of biological chemistry.

[373]  J. Chamberlain,et al.  Muscular dystrophy: The worm turns to genetic disease , 2000, Current Biology.

[374]  C. Ponting,et al.  Alternative splicing of dystrobrevin regulates the stoichiometry of syntrophin binding to the dystrophin protein complex , 2000, Current Biology.

[375]  A. Mondul,et al.  Dystrophin Associates With Caveolae of Rat Cardiac Myocytes: Relationship to Dystroglycan , 2000, Circulation research.

[376]  M. Solimena,et al.  The receptor tyrosine phosphatase-like protein ICA512 binds the PDZ domains of β2-syntrophin and nNOS in pancreatic β-cells , 2000 .

[377]  S. Fine,et al.  Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[378]  P. Tonali,et al.  γ1- and γ2-Syntrophins, Two Novel Dystrophin-binding Proteins Localized in Neuronal Cells* , 2000, The Journal of Biological Chemistry.

[379]  H. Hama,et al.  Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy. , 2000, Human molecular genetics.

[380]  R. Steinhardt,et al.  Calcium Influx through Calcium Leak Channels Is Responsible for the Elevated Levels of Calcium-dependent Proteolysis in Dystrophic Myotubes* , 2000, The Journal of Biological Chemistry.

[381]  J. Fallon,et al.  The Small Leucine-Rich Repeat Proteoglycan Biglycan Binds to α-Dystroglycan and Is Upregulated in Dystrophic Muscle , 2000, The Journal of cell biology.

[382]  G. Butler-Browne,et al.  Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children , 2000, Neuromuscular Disorders.

[383]  Simon C Watkins,et al.  Filamin 2 (FLN2): A Muscle-specific Sarcoglycan Interacting Protein , 2000 .

[384]  M. Badalamente,et al.  Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition , 2000, Muscle & nerve.

[385]  H. Jarrett,et al.  Phosphorylation of dystrophin and alpha-syntrophin by Ca(2+)-calmodulin dependent protein kinase II. , 1999, Biochimica et biophysica acta.

[386]  J. Gillis,et al.  Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse , 1999, Journal of Muscle Research & Cell Motility.

[387]  F. Sotgia,et al.  Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy. , 1999, Biochemical and biophysical research communications.

[388]  Harry Hines Boulevard,et al.  Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies , 1999, Nature Cell Biology.

[389]  G. Crawford,et al.  Interactions between β2-syntrophin and a family of microtubule-associated serine/threonine kinases , 1999, Nature Neuroscience.

[390]  E Bakker,et al.  Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in the Netherlands: a cohort study , 1999, The Lancet.

[391]  J. Chamberlain,et al.  Expression of the 71 kDa dystrophin isoform (Dp71) evaluated by gene targeting , 1999, Brain Research.

[392]  W. Lim,et al.  Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex. , 1999, Science.

[393]  P. Cohen,et al.  Stress-activated protein kinase-3 interacts with the PDZ domain of alpha1-syntrophin. A mechanism for specific substrate recognition. , 1999, The Journal of biological chemistry.

[394]  D. Bredt,et al.  Interaction of Neuronal Nitric-oxide Synthase and Phosphofructokinase-M* , 1999, The Journal of Biological Chemistry.

[395]  J. Sanes,et al.  Membrane Targeting and Stabilization of Sarcospan Is Mediated by the Sarcoglycan Subcomplex , 1999, The Journal of cell biology.

[396]  J. Sanes,et al.  Role for α-Dystrobrevin in the Pathogenesis of Dystrophin-Dependent Muscular Dystrophies , 1999, Nature cell biology.

[397]  K. Föhr,et al.  Increased calcium entry into dystrophin‐deficient muscle fibres of MDX and ADR‐MDX mice is reduced by ion channel blockers , 1999, The Journal of physiology.

[398]  J. Lefaucheur,et al.  Hindlimb immobilization applied to 21-day-old mdx mice prevents the occurrence of muscle degeneration. , 1999, Journal of applied physiology.

[399]  E. Ralston,et al.  Caveolin-3 is associated with the T-tubules of mature skeletal muscle fibers. , 1999, Experimental cell research.

[400]  P. Huang,et al.  Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[401]  Nicolas Deconinck,et al.  Expression of full-length utrophin prevents muscular dystrophy in mdx mice , 1998, Nature Medicine.

[402]  M. Beal,et al.  Evidence of oxidative stress in mdx mouse muscle: Studies of the pre-necrotic state , 1998, Journal of the Neurological Sciences.

[403]  S. Ohki,et al.  Solution structure of a protein inhibitor of neuronal nitric oxide synthase , 1998, Nature Structural Biology.

[404]  J. Ervasti,et al.  A Cluster of Basic Repeats in the Dystrophin Rod Domain Binds F-actin through an Electrostatic Interaction* , 1998, The Journal of Biological Chemistry.

[405]  B. Polla,,et al.  Effects of iron deprivation on the pathology and stress protein expression in murine X-linked muscular dystrophy. , 1998, Biochemical pharmacology.

[406]  J. Sanes,et al.  Differential Membrane Localization and Intermolecular Associations of α-Dystrobrevin Isoforms in Skeletal Muscle , 1998, The Journal of cell biology.

[407]  R. Huganir,et al.  Characterization of the tyrosine phosphorylation and distribution of dystrobrevin isoforms , 1998, FEBS letters.

[408]  Wenrong Wu,et al.  Increased caveolin‐3 levels in mdx mouse muscles , 1998, FEBS letters.

[409]  K. Campbell,et al.  Caveolin‐3 is not an integral component of the dystrophin glycoprotein complex , 1998, FEBS letters.

[410]  T. Rando,et al.  Muscle cells from mdx mice have an increased susceptibility to oxidative stress , 1998, Neuromuscular Disorders.

[411]  G. D. Thomas,et al.  Nitric oxide mediates contraction‐induced attenuation of sympathetic vasoconstriction in rat skeletal muscle , 1998, The Journal of physiology.

[412]  N. Hirokawa,et al.  Kinesin and dynein superfamily proteins and the mechanism of organelle transport. , 1998, Science.

[413]  J. Caldwell,et al.  Interaction of Muscle and Brain Sodium Channels with Multiple Members of the Syntrophin Family of Dystrophin-Associated Proteins , 1998, The Journal of Neuroscience.

[414]  L. Kunkel,et al.  beta-dystrobrevin, a new member of the dystrophin family. Identification, cloning, and protein associations. , 1997, The Journal of biological chemistry.

[415]  J. Ervasti,et al.  Dystrophin-Glycoprotein Complex Is Monomeric and Stabilizes Actin Filaments in Vitro through a Lateral Association* , 1997, The Journal of Biological Chemistry.

[416]  H. Ju,et al.  Interaction of Neuronal Nitric-oxide Synthase with Caveolin-3 in Skeletal Muscle , 1997, The Journal of Biological Chemistry.

[417]  J. Sanes,et al.  Skeletal and Cardiac Myopathies in Mice Lacking Utrophin and Dystrophin: A Model for Duchenne Muscular Dystrophy , 1997, Cell.

[418]  Susan C. Brown,et al.  Utrophin-Dystrophin-Deficient Mice as a Model for Duchenne Muscular Dystrophy , 1997, Cell.

[419]  G. Butler-Browne,et al.  Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy. , 1997, Human gene therapy.

[420]  M. F. Peters,et al.  Differential Association of Syntrophin Pairs with the Dystrophin Complex , 1997, The Journal of cell biology.

[421]  Newbell Bj,et al.  Ca2+-calmodulin binding to mouse alpha1 syntrophin: syntrophin is also a Ca2+-binding protein. , 1997 .

[422]  V. Mildažienė,et al.  Dependence of H2O2 Formation by Rat Heart Mitochondria on Substrate Availability and Donor Age , 1997, Journal of bioenergetics and biomembranes.

[423]  J. Haycock,et al.  Oxidative damage to muscle protein in Duchenne muscular dystrophy , 1996, Neuroreport.

[424]  E. Hoffman,et al.  Autosomal recessive muscular dystrophy and mutations of the sarcoglycan complex , 1996, Neuromuscular Disorders.

[425]  S. Snyder,et al.  PIN: An Associated Protein Inhibitor of Neuronal Nitric Oxide Synthase , 1996, Science.

[426]  R. Steinhardt,et al.  A critical evaluation of resting intracellular free calcium regulation in dystrophic mdx muscle. , 1996, The American journal of physiology.

[427]  J. Malin,et al.  Muscle phosphofructokinase deficiency in two generations , 1996, Journal of Neurological Sciences.

[428]  J. Stull,et al.  Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[429]  D. Bredt,et al.  Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy , 1996, The Journal of experimental medicine.

[430]  M. Lisanti,et al.  Expression of Caveolin-3 in Skeletal, Cardiac, and Smooth Muscle Cells , 1996, The Journal of Biological Chemistry.

[431]  M. E. Kargacin,et al.  The sarcoplasmic reticulum calcium pump is functionally altered in dystrophic muscle. , 1996, Biochimica et biophysica acta.

[432]  J. A. Nichol,et al.  Ca2+ loading reduces the tensile strength of sarcolemmal vesicles shed from rabbit muscle. , 1996, The Journal of physiology.

[433]  D. Bredt,et al.  Neuronal Nitric-oxide Synthase-, an Alternatively Spliced Isoform Expressed in Differentiated Skeletal Muscle (*) , 1996, The Journal of Biological Chemistry.

[434]  M. F. Peters,et al.  Isoform Diversity of Dystrobrevin, the Murine 87-kDa Postsynaptic Protein (*) , 1996, The Journal of Biological Chemistry.

[435]  E. Chin,et al.  The role of elevations in intracellular [Ca2+] in the development of low frequency fatigue in mouse single muscle fibres. , 1996, The Journal of physiology.

[436]  D. Bredt,et al.  Interaction of Nitric Oxide Synthase with the Postsynaptic Density Protein PSD-95 and α1-Syntrophin Mediated by PDZ Domains , 1996, Cell.

[437]  L. Lim,et al.  The Ras-related GTPase Rac1 Binds Tubulin (*) , 1996, The Journal of Biological Chemistry.

[438]  L. Kunkel,et al.  The Three Human Syntrophin Genes Are Expressed in Diverse Tissues, Have Distinct Chromosomal Locations, and Each Bind to Dystrophin and Its Relatives (*) , 1996, The Journal of Biological Chemistry.

[439]  P. Junankar,et al.  Raised intracellular [Ca2+] abolishes excitation‐contraction coupling in skeletal muscle fibres of rat and toad. , 1995, The Journal of physiology.

[440]  K. Widhalm,et al.  Oxyradical damage and mitochondrial enzyme activities in the mdx mouse. , 1995, Neuropediatrics.

[441]  R. Abresch,et al.  Profiles of neuromuscular diseases. Becker's muscular dystrophy. , 1995, American journal of physical medicine & rehabilitation.

[442]  J. Mair,et al.  Rapid Adaptation to Eccentric Exercise-Induced Muscle Damage , 1995, International journal of sports medicine.

[443]  E. Hoffman,et al.  Phospholipase A2 activity in dystrophinopathies , 1995, Neuromuscular Disorders.

[444]  Isabelle Richard,et al.  Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A , 1995, Cell.

[445]  E. Elson,et al.  Mechanical function of dystrophin in muscle cells , 1995, The Journal of cell biology.

[446]  L. Kunkel,et al.  Syntrophin binds to an alternatively spliced exon of dystrophin , 1995, The Journal of cell biology.

[447]  E. Ozawa,et al.  Mammalian alpha 1- and beta 1-syntrophin bind to the alternative splice- prone region of the dystrophin COOH terminus , 1995, The Journal of cell biology.

[448]  H. Jockusch,et al.  Extent of shock-induced membrane leakage in human and mouse myotubes depends on dystrophin. , 1995, Journal of cell science.

[449]  R. Huganir,et al.  Tyrosine and Serine Phosphorylation of Dystrophin and the 58‐kDa Protein in the Postsynaptic Membrane of Torpedo Electric Organ , 1994, Journal of neurochemistry.

[450]  S. Snyder,et al.  Targeted disruption of the neuronal nitric oxide synthase gene , 1993, Cell.

[451]  M. S. Clarke,et al.  Loss of cytoplasmic basic fibroblast growth factor from physiologically wounded myofibers of normal and dystrophic muscle. , 1993, Journal of cell science.

[452]  H. Sweeney,et al.  Adaptations in myosin heavy chain expression and contractile function in dystrophic mouse diaphragm. , 1993, The American journal of physiology.

[453]  M. F. Peters,et al.  Two forms of mouse syntrophin, a 58 kd dystrophin-associated protein, differ in primary structure and tissue distribution , 1993, Neuron.

[454]  J. Ervasti,et al.  A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin , 1993, The Journal of cell biology.

[455]  G. Maréchal,et al.  Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch , 1993, Journal of Muscle Research & Cell Motility.

[456]  D. Allen,et al.  Intracellular calcium concentration during low-frequency fatigue in isolated single fibers of mouse skeletal muscle. , 1993, Journal of applied physiology.

[457]  J. Gillis,et al.  Critical evaluation of cytosolic calcium determination in resting muscle fibres from normal and dystrophic (mdx) mice. , 1993, Cell calcium.

[458]  V. Chapman,et al.  New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin , 1993, Nature Genetics.

[459]  D. Bentley,et al.  Exon structure of the human dystrophin gene. , 1993, Genomics.

[460]  H. Sweeney,et al.  Dystrophin protects the sarcolemma from stresses developed during muscle contraction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[461]  R. Huganir,et al.  The 87K postsynaptic membrane protein from torpedo is a protein-tyrosine kinase substrate homologous to dystrophin , 1993, Neuron.

[462]  K. Bushby,et al.  The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy , 1993, Journal of Neurology.

[463]  K. Bushby,et al.  The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy , 1993, Journal of Neurology.

[464]  J. Ervasti,et al.  Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle , 1992, Nature.

[465]  J. Tidball,et al.  Calpain concentration is elevated although net calcium-dependent proteolysis is suppressed in dystrophin-deficient muscle. , 1992, Experimental cell research.

[466]  Y. Nonomura,et al.  Molecular shape of dystrophin. , 1992, Journal of biochemistry.

[467]  O. Hutter,et al.  The membrane hypothesis of duchenne muscular dystrophy: Quest for functional evidence , 1992, Journal of Inherited Metabolic Disease.

[468]  M. Araki,et al.  Increased leakage of calcium ion from the sarcoplasmic reticulum of the mdx mouse , 1992, Journal of the Neurological Sciences.

[469]  G. Porter,et al.  Dystrophin Colocalizes with -spectrin in Distinct Subsarcolemmal Domains in Mammalian Skeletal Muscle , 1992 .

[470]  O. Hutter,et al.  Mechanical properties of normal andmdx mouse sarcolemma: Bearing on function of dystrophin , 1991, Journal of Muscle Research & Cell Motility.

[471]  J. Shrager,et al.  The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy , 1991, Nature.

[472]  C. A. Peres,et al.  Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy , 1991, Journal of the Neurological Sciences.

[473]  H. Jockusch,et al.  Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse , 1991, Nature.

[474]  H. Blau,et al.  Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: Implications for cell and gene therapy , 1990, Somatic cell and molecular genetics.

[475]  J. Lansman,et al.  Calcium entry through stretch-inactivated ion channels in mdx myotubes , 1990, Nature.

[476]  L. Kunkel,et al.  Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. , 1990, The Journal of biological chemistry.

[477]  K. Davies,et al.  Very mild muscular dystrophy associated with the deletion of 46% of dystrophin , 1990, Nature.

[478]  J. Miller,et al.  Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. , 1989, The New England journal of medicine.

[479]  B. Cooper,et al.  Canine X-linked muscular dystrophy An animal model of Duchenne muscular dystrophy: Clinical studies , 1988, Journal of the Neurological Sciences.

[480]  E. Nylander,et al.  Selenium and vitamin E treatment of Duchenne muscular dystrophy: no effect on muscle function , 1988, Acta neurologica Scandinavica.

[481]  R. Steinhardt,et al.  Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice , 1988, Nature.

[482]  A. Sevanian,et al.  Lipid peroxidation and phospholipase A2 activity in liposomes composed of unsaturated phospholipids: a structural basis for enzyme activation. , 1988, Biochimica et biophysica acta.

[483]  Jamel Chelly,et al.  Transcription of the dystrophin gene in human muscle and non-muscle tissues , 1988, Nature.

[484]  Simon C Watkins,et al.  Immunoelectron microscopic localization of dystrophin in myofibres , 1988, Nature.

[485]  H. Blau,et al.  Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy , 1988, Cell.

[486]  M. Zatz,et al.  Relation between height and clinical course in Duchenne muscular dystrophy. , 1988, American journal of medical genetics.

[487]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.

[488]  A. Monaco,et al.  Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene , 1986, Nature.

[489]  Simon C Watkins,et al.  A quantitative comparison of satellite cell ultrastructure in duchenne muscular dystrophy, polymyositis, and normal controls , 1986, Muscle & nerve.

[490]  L. Kunkel,et al.  Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy , 1986, Nature.

[491]  I. Gamstorp,et al.  A Trial of Selenium and Vitamin E in Boys With Muscular Dystrophy , 1986, Journal of child neurology.

[492]  J. Putney,et al.  A model for receptor-regulated calcium entry. , 1986, Cell calcium.

[493]  Simon C Watkins,et al.  HISTOCHEMICAL FIBRE TYPING AND ULTRASTUCTURE OF THE SMALL FIBRES IN DUCHENNE MUSCULAR DYSTROPHY , 1985, Neuropathology and applied neurobiology.

[494]  A. Monaco,et al.  Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[495]  H. Kainulainen,et al.  Vitamin E deficiency and the susceptibility to lipid peroxidation of mouse cardiac and skeletal muscles. , 1984, Acta physiologica Scandinavica.

[496]  F Sachs,et al.  Stretch‐activated single ion channel currents in tissue‐cultured embryonic chick skeletal muscle. , 1984, The Journal of physiology.

[497]  H. Willard,et al.  Duchenne muscular dystrophy involving translocation of the dmd gene next to ribosomal RNA genes. , 1984, Science.

[498]  K. Moore,et al.  X chromosome-linked muscular dystrophy (mdx) in the mouse. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[499]  H. Blau,et al.  Defective myoblasts identified in Duchenne muscular dystrophy. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[500]  K. Davies,et al.  Linkage analysis of two cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short arm of the human X chromosome. , 1983, Nucleic acids research.

[501]  S. Street,et al.  Lateral transmission of tension in frog myofibers: A myofibrillar network and transverse cytoskeletal connections are possible transmitters , 1983, Journal of cellular physiology.

[502]  R. J. Pellegrino,et al.  Drug trial of superoxide dismutase in Duchenne's muscular dystrophy. , 1982, Archives of neurology.

[503]  M. Hallett,et al.  Muscle phosphofructokinase deficiency , 1981, Neurology.

[504]  K. Fischbeck,et al.  Freeze-fracture studies of muscle caveolae in human muscular dystrophy. , 1981, The American journal of pathology.

[505]  L. Tomasi Reversibility of human myopathy caused by vitamin E deficiency , 1979, Neurology.

[506]  J. Bodensteiner,et al.  Intracellular calcium accumulation in Duchenne dystrophy and other myopathies , 1978, Neurology.

[507]  P A Merton,et al.  Fatigue of long duration in human skeletal muscle after exercise. , 1977, The Journal of physiology.

[508]  B. Mokri,et al.  Duchenne dystrophy , 1975, Neurology.

[509]  W. Bradley,et al.  Failure to confirm a vascular cause of muscular dystrophy. , 1975, Archives of neurology.

[510]  Becker Pe Two families of benign sex-linked recessive muscular dystrophy. , 1962 .

[511]  Michael P. Siegel,et al.  Defects in mitochondrial localization and ATP synthesis in the mdx mouse model of Duchenne muscular dystrophy are not alleviated by PDE5 inhibition. , 2013, Human molecular genetics.

[512]  Jian Yang,et al.  Structure and function of the β subunit of voltage-gated Ca 2+ channels , 2013 .

[513]  G. Wiche,et al.  The many faces of plectin and plectinopathies: pathology and mechanisms , 2012, Acta Neuropathologica.

[514]  John K. Hall,et al.  Animal models of muscular dystrophy. , 2012, Progress in molecular biology and translational science.

[515]  C. Bourcier-Lucas,et al.  Stress-induced opening of the permeability transition pore in the dystrophin-deficient heart is attenuated by acute treatment with sildenafil. , 2011, American journal of physiology. Heart and circulatory physiology.

[516]  C. Minetti,et al.  Caveolinopathies: translational implications of caveolin-3 in skeletal and cardiac muscle disorders. , 2011, Handbook of clinical neurology.

[517]  C. Mann,et al.  Cellular and molecular mechanisms regulating fibrosis in skeletal muscle repair and disease. , 2011, Current topics in developmental biology.

[518]  J. Beavo,et al.  Evaluation of the therapeutic utility of phosphodiesterase 5A inhibition in the mdx mouse model of duchenne muscular dystrophy. , 2011, Handbook of experimental pharmacology.

[519]  Y. Hayashi,et al.  The 8th and 9th tandem spectrin-like repeats of utrophin cooperatively form a functional unit to interact with polarity-regulating kinase PAR-1b. , 2010, Biochemical and biophysical research communications.

[520]  L. Birnbaumer,et al.  Role of TRPC1 channel in skeletal muscle function. , 2010, American journal of physiology. Cell physiology.

[521]  G. Isenberg,et al.  Mechanical deformation of ventricular myocytes modulates both TRPC6 and Kir2.3 channels. , 2009, Cell Calcium.

[522]  E. Ríos The cell boundary theorem: a simple law of the control of cytosolic calcium concentration , 2009, The Journal of Physiological Sciences.

[523]  J. Chamberlain,et al.  The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies. , 2008, Current topics in developmental biology.

[524]  D. Allen,et al.  Skeletal muscle fatigue: cellular mechanisms. , 2008, Physiological reviews.

[525]  Baohua Yang,et al.  TNF-alpha potentiates protein-tyrosine nitration through activation of NADPH oxidase and eNOS localized in membrane rafts and caveolae of bovine aortic endothelial cells. , 2007, American journal of physiology. Heart and circulatory physiology.

[526]  C. Cognard,et al.  Regulation of capacitative calcium entries by alpha1-syntrophin: association of TRPC1 with dystrophin complex and the PDZ domain of alpha1-syntrophin. , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[527]  Nicola Maffulli,et al.  Creatine kinase monitoring in sport medicine. , 2007, British medical bulletin.

[528]  A. Kurosky,et al.  Revisiting TRPC1 and TRPC6 mechanosensitivity , 2007, Pflügers Archiv - European Journal of Physiology.

[529]  K. Krause,et al.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.

[530]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[531]  M. Rafii,et al.  Biglycan binds to alpha- and gamma-sarcoglycan and regulates their expression during development. , 2006, Journal of cellular physiology.

[532]  D. Burkin,et al.  Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin. , 2006, Journal of cell science.

[533]  M. Boppart,et al.  Alpha7beta1-integrin regulates mechanotransduction and prevents skeletal muscle injury. , 2006, American journal of physiology. Cell physiology.

[534]  J. Percival,et al.  gamma-Syntrophin scaffolding is spatially and functionally distinct from that of the alpha/beta syntrophins. , 2006, Experimental cell research.

[535]  H. Jarrett,et al.  Binding of laminin alpha1-chain LG4-5 domain to alpha-dystroglycan causes tyrosine phosphorylation of syntrophin to initiate Rac1 signaling. , 2006, Biochemistry.

[536]  L. Kunkel 2004 William Allan Award address. Cloning of the DMD gene. , 2005, American journal of human genetics.

[537]  Gregory Q. Wallace,et al.  Transgenic Expression of (cid:1) 7 (cid:2) 1 Integrin Maintains Muscle Integrity, Increases Regenerative Capacity, Promotes Hypertrophy, and Reduces Cardiomyopathy in Dystrophic Mice , 2004 .

[538]  Y. Wakayama,et al.  Size and localization of dystrophin molecule: immunoelectron microscopic and freeze etching studies of muscle plasma membranes of murine skeletal myofibers , 2004, Acta Neuropathologica.

[539]  M. Rudnicki,et al.  Cellular and molecular regulation of muscle regeneration. , 2004, Physiological reviews.

[540]  K. Shitara,et al.  Alpha1-syntrophin modulates turnover of ABCA1. , 2004, The Journal of biological chemistry.

[541]  R. Bloch,et al.  Differential distribution of dystrophin and β-spectrin at the sarcolemma of fast twitch skeletal muscle fibers , 2004, Journal of Muscle Research & Cell Motility.

[542]  M. Grounds,et al.  Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis. , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[543]  K. Mathews,et al.  Limb-girdle muscular dystrophy , 2003, Current neurology and neuroscience reports.

[544]  J. Sanes,et al.  Tyrosine-phosphorylated and nonphosphorylated isoforms of alpha-dystrobrevin: roles in skeletal muscle and its neuromuscular and myotendinous junctions. , 2003, The Journal of cell biology.

[545]  J. Stamler,et al.  Physiology of nitric oxide in skeletal muscle. , 2001, Physiological reviews.

[546]  Simon C Watkins,et al.  Desmuslin, an intermediate filament protein that interacts with alpha -dystrobrevin and desmin. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[547]  K. Suzuki,et al.  Skeletal muscle-specific calpain, p94, and connectin/titin: their physiological functions and relationship to limb-girdle muscular dystrophy type 2A. , 2000, Advances in Experimental Medicine and Biology.

[548]  M. Solimena,et al.  The receptor tyrosine phosphatase-like protein ICA512 binds the PDZ domains of beta2-syntrophin and nNOS in pancreatic beta-cells. , 2000, European journal of cell biology.

[549]  P. Tonali,et al.  Gamma1- and gamma2-syntrophins, two novel dystrophin-binding proteins localized in neuronal cells. , 2000, The Journal of biological chemistry.

[550]  D. Bredt,et al.  Regulation of neuronal nitric oxide synthase through alternative transcripts. , 1997, Developmental neuroscience.

[551]  H. Jarrett,et al.  Ca2+-calmodulin binding to mouse alpha1 syntrophin: syntrophin is also a Ca2+-binding protein. , 1997, Biochemistry.

[552]  D. A. Williams,et al.  Contractile properties of skinned muscle fibres from young and adult normal and dystrophic (mdx) mice. , 1993, The Journal of physiology.

[553]  P. Mcneil,et al.  Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. , 1992, The American journal of pathology.

[554]  D. A. Williams,et al.  Physiological properties of skinned fibres from normal and dystrophic (Duchenne) human muscle activated by Ca2+ and Sr2+. , 1990, The Journal of physiology.

[555]  A. Sevanian,et al.  Phospholipase A2 dependent release of fatty acids from peroxidized membranes. , 1985, Journal of free radicals in biology & medicine.

[556]  M. Zatz,et al.  Benign Duchenne muscular dystrophy in a patient with growth hormone deficiency. , 1981, American journal of medical genetics.

[557]  M. Zatz,et al.  Begnign duchenne muscular dystrophy in a patient with growth hormone deficiency , 1981 .

[558]  A. Ossipov,et al.  Duchenne muscular dystrophy , 2004 .

[559]  P. E. Becker Two families of benign sex-linked recessive muscular dystrophy. , 1962, Revue canadienne de biologie.